China Vanke Co., Ltd.
China Vanke Co., Ltd. (CHVKY) Financial Performance & Income Statement Overview
Analyze China Vanke Co., Ltd. (CHVKY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
China Vanke Co., Ltd. (CHVKY) Income Statement & Financial Overview
View the income breakdown for China Vanke Co., Ltd. CHVKY across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $37.99B | $123.28B | $77.12B | $78.98B |
| Cost of Revenue | $35.68B | $109.26B | $67.81B | $76.26B |
| Gross Profit | $2.32B | $14.02B | $9.31B | $2.71B |
| Gross Profit Ratio | $0.06 | $0.11 | $0.12 | $0.03 |
| R&D Expenses | $106.17M | $138.51M | $142.46M | $88.75M |
| SG&A Expenses | $2.61B | $5.49B | $4.09B | $4.04B |
| Operating Expenses | $8.98B | $44.99B | $16.25B | $6.33B |
| Total Costs & Expenses | $44.66B | $154.26B | $84.06B | $84.39B |
| Interest Income | $0.00 | $484.71M | $490.87M | $1.59B |
| Interest Expense | $0.00 | -$11.19B | $8.76B | $1.26B |
| Depreciation & Amortization | $1.40B | -$12.15B | $8.32B | $2.22B |
| EBITDA | -$974.26M | -$43.12B | $1.38B | -$3.20B |
| EBITDA Ratio | -$0.03 | -$0.35 | $0.02 | -$0.04 |
| Operating Income | -$6.66B | -$30.98B | -$6.94B | -$5.42B |
| Operating Income Ratio | -$0.18 | -$0.25 | -$0.09 | -$0.07 |
| Other Income/Expenses (Net) | -$70.16M | -$770.03M | -$443.95M | -$3.34B |
| Income Before Tax | -$6.73B | -$31.75B | -$7.38B | -$9.78B |
| Income Before Tax Ratio | -$0.18 | -$0.26 | -$0.10 | -$0.12 |
| Income Tax Expense | $315.78M | $559.24M | $494.40M | $95.66M |
| Net Income | -$6.25B | -$31.54B | -$8.09B | -$9.49B |
| Net Income Ratio | -$0.16 | -$0.26 | -$0.10 | -$0.12 |
| EPS | -$0.53 | -$2.66 | -$0.68 | -$0.80 |
| Diluted EPS | -$0.53 | -$2.66 | -$0.68 | -$0.80 |
| Weighted Avg Shares Outstanding | $11.86B | $11.86B | $11.86B | $11.86B |
| Weighted Avg Shares Outstanding (Diluted) | $11.86B | $11.86B | $11.86B | $11.86B |
Over the last four quarters, China Vanke Co., Ltd.'s revenue moved from $78.98B in Q2 2024 to $37.99B in Q1 2025. Operating income in Q1 2025 was -$6.66B, with a strong operating margin of -18%. Despite fluctuations in R&D and SG&A expenses, EBITDA for China Vanke Co., Ltd. remained robust at -$974.26M, reflecting operational efficiency. Net income rose to -$6.25B, with an EPS of -$0.53. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan